Drug combinations containing AZT
US5116823A · kind A · utility
9Cited by
3References
5Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 27, 1990 |
| Grant date | May 26, 1992 |
| Priority date | — |
| Expiry date | Feb 27, 2010 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/505
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Combinations of 3'-azido-3'-deoxythymidine (AZT) with 5-fluorouracil (FUra) or its precursor 5-fluoro-2'-deoxyuridine (FUDR) or methoxtrexate (MTX) exhibit increased cytotoxicity and increased therapeutic index in treatment of carcinomas.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.